AGN-151586 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10 (month) in 11d
ESTIMATED |
READOUT
A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treat
Phase 2 · Forehead Lines |
ABBV AbbVie Inc. | AGN-151586 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|